<DOC>
	<DOCNO>NCT01201785</DOCNO>
	<brief_summary>Since diabetic platelet characterize enhanced turnover rate , may hypothesize increase frequency , rather dose , drug administration may effective strategy inhibit platelet reactivity diabetic patient may enable COX-1 blockade newly generate platelet . However , different dose regimen impact pharmacodynamic effect aspirin selectively diabetes mellitus poorly explore . Therefore , aim present pilot investigation evaluate increase frequency aspirin administration , remain within daily recommend therapeutic dos , affect antiplatelet responsiveness diabetic patient coronary artery disease .</brief_summary>
	<brief_title>Aspirin Dosing Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Medically treat ( take oral hypoglycemic medication and/or insulin ) type 2 diabetes mellitus patient 18 75 year stable coronary artery disease Blood dyscrasia bleed diathesis Oral anticoagulation therapy coumadin derivative Recent antiplatelet treatment ( &lt; 30 day ) glycoprotein IIb/IIIa antagonist , thienopyridine ( ticlopidine , clopidogrel ) , cilostazol dipyridamole Platelet count &lt; 100 /microL History gastrointestinal bleed within last 6 month History cerebrovascular accident within last 3 month History hospitalization acute coronary event coronary revascularization ( percutaneous surgical ) past 12 month Active bleed hemodynamic instability Any active malignancy Serum creatinine &gt; 2 mg/dL Baseline ALT &gt; 2.5 time upper limit normal Pregnant female HbA1C &gt; 10 % Use nonsteroidal antiinflammatory drug past 10 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>diabetes mellitus , coronary artery disease , aspirin therapy</keyword>
</DOC>